ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Immunome Inc

Immunome Inc (IMNM)

10.76
-0.44
(-3.93%)
At close: January 07 3:00PM
10.6502
-0.1098
( -1.02% )
After Hours: 4:49PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
10.6502
Bid
10.65
Ask
11.10
Volume
366,127
10.71 Day's Range 11.60
8.97 52 Week Range 30.958
Market Cap
Previous Close
11.20
Open
11.245
Last Trade
2
@
11.06
Last Trade Time
17:27:29
Financial Volume
US$ 4,055,943
VWAP
11.078
Average Volume (3m)
801,071
Shares Outstanding
62,416,845
Dividend Yield
-
PE Ratio
-6.28
Earnings Per Share (EPS)
-1.71
Revenue
14.02M
Net Profit
-106.81M

About Immunome Inc

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious... Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Immunome Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IMNM. The last closing price for Immunome was US$11.20. Over the last year, Immunome shares have traded in a share price range of US$ 8.97 to US$ 30.958.

Immunome currently has 62,416,845 shares outstanding. The market capitalization of Immunome is US$699.07 million. Immunome has a price to earnings ratio (PE ratio) of -6.28.

IMNM Latest News

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

SAN FRANCISCO and SINGAPORE, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat...

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Immunome, Inc. (the β€œCompany”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on January 2, 2025...

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Immunome, Inc. (the β€œCompany”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on December 2, 2024...

Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome’s management will...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.22022.1112176414210.4311.55510.200171861210.87312524CS
4-3.7098-25.834261838414.3614.4210.1185461611.39353619CS
12-1.4998-12.344032921812.1515.1258.9780107111.58069301CS
26-1.4698-12.127062706312.1216.818.9771140812.86876775CS
52-0.6998-6.1656387665211.3530.9588.9778908615.35178113CS
156-1.1598-9.8204911092311.8130.9582.0932340513.76529316CS
260-5.0098-31.991060025515.6663.782.0928727515.6376667CS

IMNM - Frequently Asked Questions (FAQ)

What is the current Immunome share price?
The current share price of Immunome is US$ 10.6502
How many Immunome shares are in issue?
Immunome has 62,416,845 shares in issue
What is the market cap of Immunome?
The market capitalisation of Immunome is USD 699.07M
What is the 1 year trading range for Immunome share price?
Immunome has traded in the range of US$ 8.97 to US$ 30.958 during the past year
What is the PE ratio of Immunome?
The price to earnings ratio of Immunome is -6.28
What is the cash to sales ratio of Immunome?
The cash to sales ratio of Immunome is 47.86
What is the reporting currency for Immunome?
Immunome reports financial results in USD
What is the latest annual turnover for Immunome?
The latest annual turnover of Immunome is USD 14.02M
What is the latest annual profit for Immunome?
The latest annual profit of Immunome is USD -106.81M
What is the registered address of Immunome?
The registered address for Immunome is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Immunome website address?
The website address for Immunome is www.immunome.com
Which industry sector does Immunome operate in?
Immunome operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SANASana Biotechnology Inc
US$ 7.44
(350.91%)
24.98M
JBDIJBDI Holdings Ltd
US$ 0.90
(27.12%)
6.73M
MCVTMill City Ventures III Ltd
US$ 3.89
(25.08%)
212.33k
CDTConduit Pharmaceuticals Inc
US$ 0.117
(24.47%)
21.56M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.1402
(21.91%)
48.96M
XTIAXTI Aerospace Inc
US$ 0.0609
(-46.63%)
221.53M
ALKTAlkami Technology Inc
US$ 25.50
(-27.91%)
13.87k
DRIODarioHealth Corporation
US$ 1.1109
(-27.39%)
400.07k
AREBAmerican Rebel Holdings Inc
US$ 2.18
(-21.86%)
668.16k
TOIIWOncology Institute Inc
US$ 0.0124
(-20.51%)
322
XTIAXTI Aerospace Inc
US$ 0.0609
(-46.63%)
221.53M
SVMHSRIVARU Holding Ltd
US$ 0.0682
(-18.81%)
66.45M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.1402
(21.91%)
48.96M
SANASana Biotechnology Inc
US$ 7.44
(350.91%)
24.98M
CDTConduit Pharmaceuticals Inc
US$ 0.117
(24.47%)
21.56M

IMNM Discussion

View Posts
tw0122 tw0122 1 month ago
Looking good in some reverse head and shoulders at .85+4% and  .92-.99 up next. The world of DNA
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
IMNM under $15

πŸ‘οΈ0
Monksdream Monksdream 10 months ago
IMNM 10Q due 3/22
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
IMNM new 52 week hi
πŸ‘οΈ0
Monksdream Monksdream 12 months ago
IMNM new 52 week high
πŸ‘οΈ0
OncoJock OncoJock 1 year ago
Agree.

Wish there were most posts on this board.

Wondering who might be the next big customer to sign a major discovery and commercialization contract with IMNM, after AbbVie?

Also wondering if IMNM is doing any discovery/testing/research related to bispecific antibodies, as opposed to antibody-drug conjugates. Bispecifics are HOT HOT HOT in lymphoma and myeloma.

-- OJ
πŸ‘οΈ0
OncoJock OncoJock 1 year ago
agree
πŸ‘οΈ0
Laster Laster 1 year ago
Hopefully the vote passed.
I think this biotech combined company can be a huge success.
Siegall has proven he can build a biotech company.
This will be fun to watch.
👍️ 1
Laster Laster 1 year ago
I believe merger news tomorrow along with huge financing.
Clay B. Siegall To become chairman and CEO of combined company.
He founded Seagen which just sold for $40 billion to Pfizer.
Their innovative technology from Professor Philip S. Low (Purdue University).
Look at Professor Low accomplishments. Unreal.
Watching closely because this might become a huge biotech company.
👍️ 1
wiwineguy wiwineguy 2 years ago
Ha, sold in fall of 21 for $25.
πŸ‘οΈ0
makinezmoney makinezmoney 2 years ago
$IMNM: Now 10.40 !!!!!!!!!!!

Booooooooooooyakashaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa


Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies



GO $IMNM
πŸ‘οΈ0
makinezmoney makinezmoney 2 years ago
$IMNM: Boooommmmmmmmmmmmmmm.......now $8.50


Offfffffffffff she goes.

Nice boomer



GO $IMNM
πŸ‘οΈ0
Awl416 Awl416 2 years ago
Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies
👍️ 1
wiwineguy wiwineguy 3 years ago
you don't know crap majorbankz. you keep saying i "heard" this, and I "heard" that. can you be any more vague. stfu
πŸ‘οΈ0
Harbor6460 Harbor6460 3 years ago
They cannot dilute on the bid. Only the ask
πŸ‘οΈ0
Pedro2004 Pedro2004 3 years ago
Pulled down to under $20.00
πŸ‘οΈ0
Pedro2004 Pedro2004 3 years ago
They pulled this down to under $21.00

I'm back-in at $21.00
πŸ‘οΈ0
Major_Bankz Major_Bankz 3 years ago
$22.50 U worry too much, should be $25+ this afternoon IMO
πŸ‘οΈ0
Pedro2004 Pedro2004 3 years ago
I thought this was going to break today. But it' just jumped over $22 -- let's see if that holds.
πŸ‘οΈ0
Pedro2004 Pedro2004 3 years ago
This run could have broke $30 today. But the company killed-it.
πŸ‘οΈ0
Major_Bankz Major_Bankz 3 years ago
yep, shorties portfolio will get destroyed here.
πŸ‘οΈ0
Pedro2004 Pedro2004 3 years ago
The dilution is going to kill this run.
πŸ‘οΈ0
Pedro2004 Pedro2004 3 years ago
Looks like the company is dumping shares on the bid.
πŸ‘οΈ0
Major_Bankz Major_Bankz 3 years ago
I don't think PFE and MRNA can claim the same effectiveness for DELTA, plus time to buy is during development not after just like when MRNA was at $20. IMO
πŸ‘οΈ0
Major_Bankz Major_Bankz 3 years ago
Delta is a BIG problem, IMNM may catch up to PFE and MRNA. IMO
πŸ‘οΈ0
Major_Bankz Major_Bankz 3 years ago
Immunome was awarded a $17.6 million technology award from the U.S. Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), in collaboration with the Defense Health Agency, to support Immunome’s COVID program.

Given the near-term potential for a resurgence of COVID-19 infections driven by emerging variants, Immunome intends to explore opportunities to expedite the development of this potential therapeutic. The Company plans to submit an IND application with the U.S. Food and Drug Administration (FDA) this quarter.
πŸ‘οΈ0
Major_Bankz Major_Bankz 3 years ago
IMNM $21 Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock